🪞 Bruce Berkowitz · Fairholme
Concentrated value.
Hit rate is measured, not predicted: across 2,030 investor-quarters of walk-forward holdout, the name this model ranked first was the investor’s actual next new buy 1.7% of the time, against 0.62% for a name drawn at random from the same board. That is 2.77x chance. The model ranks the whole board; AUC and the rest of the scoring detail are on the how it works page.
Build a basket from the top picks →
🔮 Predicted next buys: quarter ending 2026-09-30
The model orders Bruce Berkowitz · Fairholme’s candidates for the next 13F filing. No public confirmation yet. The rate beside each name is the model’s own score rewritten as a measured quantity: how often a name in that position turned out to be the next buy across 2,030 investor-quarters of holdout. Picking at random from this board lands 0.62%.
| # | Ticker | Company | Measured hit rate | vs base |
|---|---|---|---|---|
| 1 | RRC | Range Resources Corp | 1.8% | 2.9x |
| 2 | UPS | United Parcel Service-Cl B | 1.7% | 2.8x |
| 3 | DHI | Dr Horton Inc | 1.7% | 2.8x |
| 4 | CPB | The Campbell'S Company | 1.7% | 2.7x |
| 5 | ABT | Abbott Laboratories | 1.6% | 2.6x |
| 6 | DT | Dynatrace Inc | 1.6% | 2.6x |
| 7 | MCHP | Microchip Technology Inc | 1.6% | 2.5x |
| 8 | TME | Tencent Music Entertainm-Adr | 1.5% | 2.5x |
| 9 | DPZ | Domino'S Pizza Inc | 1.5% | 2.4x |
| 10 | HOMB | Home Bancshares Inc | 1.5% | 2.4x |
📉 Predicted exits, conviction fading
Of Bruce Berkowitz · Fairholme’s current disclosed holdings, the names a model flags as most likely to be EXITED or TRIMMED next quarter, before the 13F shows it. Model score (not a calibrated probability), ranked. Holdings as of 2026-06-30.
| Ticker | Company | Weight | Last move | Sell likelihood |
|---|---|---|---|---|
| - | Berkshire Hathaway Inc Del | 0.55% | added last Q | ▲ 59 |
| KHC | Kraft Heinz Co | 0.32% | added last Q | ▲ 59 |
| CPB | The Campbells Company | 0.17% | just entered | ▲ 54 |
| PFE | Pfizer Inc | 0.37% | just entered | ▲ 54 |
| UPS | United Parcel Svcs Inc | 0.17% | just entered | ▲ 53 |
| - | Berkshire Hathaway Inc Del | 2.95% | added last Q | ▲ 52 |
⚠️ This predicts the ACTION (whether Bruce Berkowitz · Fairholme reduces the position), not a return and not a short. A 13F shows long positions only, so a “sell” here means exiting or cutting a long, never shorting the stock. Walk-forward validated on the decision (AUC ≈ 0.66), but acting on it is not shown to make money. Research, not advice.
📜 Top disclosed holdings: Jun 2026
| Ticker | Company | Weight | Last change |
|---|---|---|---|
| JOE | St Joe Co | 76.43% | ✊ Held |
| EPD | Enterprise Prods Partners L | 13.46% | ✊ Held |
| OZK | Bank Ozk | 3.22% | ✊ Held |
| BRK/B | Berkshire Hathaway Inc Del | 2.95% | ➕ Added |
| WRB | Wr Berkley Corp | 1.21% | ✊ Held |
| PGR | Progressive Corp | 1.06% | ✊ Held |
| BRK/A | Berkshire Hathaway Inc Del | 0.55% | ➕ Added |
| PFE | Pfizer Inc | 0.37% | 🆕 New |
| KHC | Kraft Heinz Co | 0.32% | ➕ Added |
| CPB | The Campbells Company | 0.17% | 🆕 New |
| UPS | United Parcel Svcs Inc | 0.17% | 🆕 New |
| AAPL | Apple Inc | 0.05% | ✊ Held |
| HOMB | Home Bancshares Inc | 0.02% | ✊ Held |
Source: SEC Form 13F (public domain), long U.S. equity positions only, disclosed up to 45 days after quarter-end. Top 15 of 13 shown.
💲 Where they bought: accumulation cost
13F shows holdings, not trade prices. Implied average cost is total value ÷ shares; the zone is the price range that quarter, where they accumulated. “vs cost” is today versus that average. This is where they bought, not a future price.
| Ticker | Avg cost | Accumulation zone | Today | vs cost | Dip target |
|---|---|---|---|---|---|
| JOE | $62.63 | $61–$71 | $67.91 | +8.4% | $55.35 |
| EPD | $36.76 | $36–$39 | $38.82 | +5.6% | $30.58 |
| OZK | $52.09 | $45–$52 | $49.44 | -5.1% | $40.25 |
| BRK-B | $500.39 | $465–$500 | $503.70 | +0.7% | $390.21 |
| WRB | $70.53 | $63–$71 | $67.56 | -4.2% | $55.58 |
| PGR | $218.45 | $190–$224 | $217.65 | -0.4% | $174.87 |
| BRK-A | $748850.00 | $699965–$748850 | $764000.00 | +2.0% | $583962.52 |
| PFE | $24.08 | $23–$28 | $28.46 | +18.2% | $21.53 |
| KHC | $23.62 | $22–$24 | $25.13 | +6.4% | $19.02 |
| CPB | $22.27 | $20–$23 | $23.28 | +4.5% | $17.65 |
Dip target = the recent high discounted by this investor’s historical tendency to add on weakness. Behavioral, not a guarantee.
🧬 Factor fingerprint, the style behind the book
38% of Bruce Berkowitz · Fairholme’s day-to-day swings are explained by public, buyable factors (Fama-French 5 + momentum), regressed on their current disclosed book (11 of 11 names, ~421 trading days). Market beta 0.73.
⚠️ This is the part the great investors can’t hide: their style is a tilt toward known factors, and every one of these is sold as a cheap index ETF. Buying the factors gets you most of the book for a few basis points. What’s left after the factors (the residual) is noisy on a single concentrated book and is not a reliable edge, read this as transparency about the style you’re copying, not a secret signal. Loadings are in-sample on current static weights, U.S. long positions only. Research, not advice.
📈 This mirror’s track: backtest vs S&P 500
⚠️ Read this honestly. Leak-free walk-forward backtest: top-10 predicted new buys ranked from a broad ~2,000-name universe known at the rebalance date, equal-weight, 1-quarter holds, complete quarters only, gross (before costs). Small samples, per-investor edges are noisy and not statistically significant. The consensus mirror's backtest shows +2.2 pts/quarter net vs the S&P 500 over 35 complete quarters (2017Q3 to 2026Q1), directional, NOT statistically significant (t≈1.3; 95% CI includes zero). Most of that average is one quarter: 2026Q1 posted a +47.5 pt edge, roughly half of it two AI-hardware names (SNDK +258%, AMD +186%) marked at what proved to be a local peak; excluding it the edge is +0.9 pts/quarter. Past performance does not predict future results. Not investment advice.
🔔 Follow this mirror
New filings and predicted-buy refreshes are published to every reader at once, weekly digest (email) · build a basket.
Prior Moves is a research publication: one impersonal model portfolio per investor, identical for every reader. You place any trades yourself at your own broker. No execution, no custody, no individualised advice.